Drug recall

Apheresis Red Blood Cells, Leukocytes Reduced

FDA recall event 98405 · Class II · The American National Red Cross

Key facts

Event ID 98405
Recall numbers B-0012-2026, B-0013-2026, B-0014-2026, B-0015-2026, B-0016-2026
Recalling firm The American National Red Cross
Product type Biologics
Products Apheresis Red Blood Cells, Leukocytes Reduced, Red Blood Cells, Frozen, Leukocytes Reduced, Irradiated, Red Blood Cells, Leukocytes Reduced, Red Blood Cells, Leukocytes Reduced, Irradiated, Red Blood Cells, Washed, Leukocytes Reduced, Irradiated
Classification Class II
Status Terminated
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Apheresis Red Blood Cells, Leukocytes Reduced, for which Babesia testing was not performed, were distributed., Red Blood Cells, Frozen, Leukocytes Reduced, Irradiated, for which Babesia testing was not performed, were distributed., Red Blood Cells, Leukocytes Reduced, for which Babesia testing was not performed, were distributed., Red Blood Cells, Leukocytes Reduced, Irradiated, for which Babesia…
Initiation date May 10, 2023
Report date Feb 18, 2026
Termination date Feb 6, 2026
City Saint Paul
State MN
Country United States
FEI number 2173038

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls